E
11.34
-0.57 (-4.79%)
| Penutupan Terdahulu | 11.91 |
| Buka | 11.80 |
| Jumlah Dagangan | 415,215 |
| Purata Dagangan (3B) | 585,798 |
| Modal Pasaran | 659,244,096 |
| Harga / Pendapatan (P/E TTM) | 11.45 |
| Harga / Jualan (P/S) | 0.650 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2025 - 12 May 2025 |
| Hasil Dividen (DY TTM) | 3.97% |
| Margin Keuntungan | 5.25% |
| Margin Operasi (TTM) | 21.42% |
| EPS Cair (TTM) | 0.990 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -5.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -100.00% |
| Nisbah Semasa (MRQ) | 2.24 |
| Aliran Tunai Operasi (OCF TTM) | 43.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -37.41 M |
| Pulangan Atas Aset (ROA TTM) | 3.13% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Embecta Corp. | Menurun | Bercampur |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.40% |
| % Dimiliki oleh Institusi | 98.61% |
| Julat 52 Minggu | ||
| Median | 13.00 (14.64%) | |
| Jumlah | 1 Pegang | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Mizuho | 23 May 2025 | 13.00 (14.64%) | Pegang | 10.51 |
| 10 Apr 2025 | 15.00 (32.28%) | Pegang | 12.01 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 22 May 2025 | Pengumuman | embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day |
| 09 May 2025 | Pengumuman | Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results |
| 09 May 2025 | Pengumuman | embecta Announces Quarterly Cash Dividend |
| 28 Apr 2025 | Pengumuman | Embecta to host Analyst and Investor Day on May 22, 2025 |
| 21 Apr 2025 | Pengumuman | embecta to Report Fiscal Second Quarter 2025 Financial Results |
| 01 Apr 2025 | Pengumuman | Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations |
| Hasil Dividen (DY TTM) | 3.97% |
| Purata Hasil Dividen 3T | 2.49% |
| Nisbah Pembayaran | 60.61% |
| Jangkaan Pembayaran Dividen Seterusnya | Jun 2025 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 06 Dec 2024 | 26 Nov 2024 | 18 Dec 2024 | 0.15 Tunai |
| 27 Aug 2024 | 09 Aug 2024 | 13 Sep 2024 | 0.15 Tunai |
| 24 May 2024 | 09 May 2024 | 14 Jun 2024 | 0.15 Tunai |
| 27 Feb 2024 | 09 Feb 2024 | 15 Mar 2024 | 0.15 Tunai |
| 01 Dec 2023 | 21 Nov 2023 | 15 Dec 2023 | 0.15 Tunai |
| 24 Aug 2023 | 08 Aug 2023 | 13 Sep 2023 | 0.15 Tunai |
| 25 May 2023 | 12 May 2023 | 13 Jun 2023 | 0.15 Tunai |
| 24 Feb 2023 | 14 Feb 2023 | 13 Mar 2023 | 0.15 Tunai |
| 29 Dec 2022 | 20 Dec 2022 | 11 Jan 2023 | 0.15 Tunai |
| 25 Aug 2022 | 12 Aug 2022 | 14 Sep 2022 | 0.15 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 0.600 | 4 | 2.91 |
| 2023 | 0.750 | 5 | 3.96 |
| 2022 | 0.150 | 1 | 0.59 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |